A breakthrough joint medical study on an anti-Aids drug by the US and Bangkok City Hall has highlighted the need to address again the problem with health costs and, more importantly, the politically toxic issue of compulsory licensing, known as CL.
Representatives of Bangkok Metropolitan Association, Ministry of Public Health, and the US Centers for Disease Control and Prevention formally announced the results of their study of the use of tenofovir last week. (Photo provided by US Embassy, Bangkok)
The facts are simple, and they are politically intimidating. There really are only two that matter.
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.